# Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer

> **NCT01167738** · PHASE2 · TERMINATED · sponsor: **IRCCS San Raffaele** · enrollment: 60 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** cisplatin
- **DRUG:** epirubicin
- **DRUG:** gemcitabine
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT01167738
- **Lead sponsor:** IRCCS San Raffaele
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2014-12
- **Final completion:** 2015-04
- **Target enrollment:** 60 (ACTUAL)
- **Why stopped:** concern of detrimental effect
- **Last updated:** 2015-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01167738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01167738, "Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01167738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*